John H. Schrank Jr. MD
HIV/AIDS Medicine
Medical Director, AID Upstate
Join to View Full Profile
811 Pendleton StSt 10Greenville, SC 29601
Phone+1 864-250-0607
Dr. Schrank is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Schrank Jr., MD, specializes in Infectious Disease with a subspecialty in HIV/AIDS Medicine, based in Greenville, SC. He completed his medical education at Rutgers Robert Wood Johnson Medical School, followed by residency in Internal Medicine and a fellowship in Infectious Disease. Dr. Schrank is experienced in handling cases related to HIV/AIDS, wound management, and staphylococcal infections. His publication record includes articles in respected journals like Clinical Infectious Diseases and JAMA, with multiple citations for his research on vancomycin exposure and staphylococcal bacteremia. He has been involved in clinical trials focused on treatment algorithms for bloodstream infections and anti-HIV drug combinations. In 2013, he received CMS Meaningful Use Stage 1 Certification from eClinicalWorks EHR.
Education & Training
San Antonio Uniformed Services Health Education ConsortiumFellowship, Infectious Disease, 1991 - 1994
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1986 - 1989
Rutgers Robert Wood Johnson Medical SchoolClass of 1986
Certifications & Licensure
SC State Medical License 1997 - 2027
PA State Medical License 1987 - 1998
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Clinical Trials
- A Study to Compare Two Anti-HIV Drug Combinations Start of enrollment: 1999 Oct 01
- A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination Start of enrollment: 2006 Mar 01
- Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- 98 citationsThe Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patie...Thomas P. Lodise, Susan L. Rosenkranz, Matthew Finnemeyer, Scott R. Evans, Matthew Sims
Clinical Infectious Diseases. 2020-04-10 - 52 citationsEffect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical TrialThomas L. Holland, Issam I Raad, Helen W. Boucher, Deverick J. Anderson, Sara E. Cosgrove
JAMA. 2018-09-25 - 28 citationsPurulent Pericarditis Caused by Candida Species: Case Report and ReviewJohn Schrank, David P. Dooley
Clinical Infectious Diseases. 1995-07-01
Journal Articles
- Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal BacteremiaIssam Raad, Mark E Rupp, Thomas L Holland, Helen W Boucher, G Ralph Corey, Paul Riska, Deverick J Anderson, Matthew Sims, Dannah Wray, Sara E Cosgrove, Manuela Carugat..., JAMA
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
